收费全文 | 322454篇 |
免费 | 21494篇 |
国内免费 | 1470篇 |
耳鼻咽喉 | 3635篇 |
儿科学 | 8099篇 |
妇产科学 | 5715篇 |
基础医学 | 40715篇 |
口腔科学 | 6497篇 |
临床医学 | 32670篇 |
内科学 | 68712篇 |
皮肤病学 | 4646篇 |
神经病学 | 32165篇 |
特种医学 | 13642篇 |
外国民族医学 | 14篇 |
外科学 | 51434篇 |
综合类 | 3274篇 |
现状与发展 | 1篇 |
一般理论 | 368篇 |
预防医学 | 22678篇 |
眼科学 | 7222篇 |
药学 | 20854篇 |
1篇 | |
中国医学 | 455篇 |
肿瘤学 | 22621篇 |
2023年 | 2121篇 |
2022年 | 3556篇 |
2021年 | 8294篇 |
2020年 | 4659篇 |
2019年 | 7584篇 |
2018年 | 9022篇 |
2017年 | 6566篇 |
2016年 | 7140篇 |
2015年 | 8295篇 |
2014年 | 11935篇 |
2013年 | 15818篇 |
2012年 | 24125篇 |
2011年 | 24983篇 |
2010年 | 13952篇 |
2009年 | 12663篇 |
2008年 | 21601篇 |
2007年 | 22211篇 |
2006年 | 21587篇 |
2005年 | 21362篇 |
2004年 | 19889篇 |
2003年 | 18211篇 |
2002年 | 17168篇 |
2001年 | 2506篇 |
2000年 | 1891篇 |
1999年 | 2645篇 |
1998年 | 3610篇 |
1997年 | 2863篇 |
1996年 | 2449篇 |
1995年 | 2278篇 |
1994年 | 1930篇 |
1993年 | 1922篇 |
1992年 | 1323篇 |
1991年 | 1233篇 |
1990年 | 1071篇 |
1989年 | 1017篇 |
1988年 | 960篇 |
1987年 | 873篇 |
1986年 | 916篇 |
1985年 | 961篇 |
1984年 | 1247篇 |
1983年 | 1080篇 |
1982年 | 1356篇 |
1981年 | 1279篇 |
1980年 | 1081篇 |
1979年 | 613篇 |
1978年 | 703篇 |
1977年 | 625篇 |
1976年 | 545篇 |
1975年 | 444篇 |
1974年 | 438篇 |
Methods: This is a retrospective analysis of discharge records from the National Inpatient Sample database for patients receiving allo-HSCT between 1 January 2009 and 31 December 2013. Allo-HSCT discharges with an aGVHD diagnosis were included in the aGVHD group and those without any graft-versus-host disease (GVHD) diagnosis comprised the non-GVHD group. Mortality, LOS and costs were compared between the two groups, as well as within subgroups, including age (<18 vs. ≥18 years) and survival status (alive vs. deceased) at discharge.
Results: Overall, mortality (16.2% vs. 5.3%; p?<?.01), median hospital LOS (42.0 vs. 26.0 days; p?<?.01) and median total costs ($173,144 vs. $98,982; p?<?.01) were significantly increased in patients with aGVHD versus those without GVHD during hospitalizations for allo-HSCT, irrespective of age group. Patients with aGVHD who were <18 years of age had a lower mortality rate but greater hospital LOS and total costs versus patients aged ≥18 years. Patients who died during allo-HSCT hospitalization had longer LOS and incurred greater costs than those who survived in both the aGVHD and non-GVHD groups.
Conclusion: Occurrence of aGVHD during allo-HSCT admissions resulted in a tripling of the mortality rate and a near doubling of hospital LOS and total costs. In addition, death during allo-HSCT hospitalizations was associated with greater healthcare utilization and costs. Effectively mitigating aGVHD may improve survival and substantially reduce hospital LOS and costs for allo-HSCT. 相似文献
Background
The purpose of this analysis is to describe the differences in cardiac magnetic resonance characteristics between benign and malignant tumors, which would be helpful for surgical planning.Methods
This was a prospective cohort study of 130 patients who underwent cardiac magnetic resonance imaging for evaluation of a suspected cardiac mass. After excluding thrombi and tumors without definitive diagnosis, 66 tumors were evaluated for morphologic features and tissue composition.Results
Of the 66 patients, 39 (59.0%) had malignant tumors and 27 (41.0%) had benign tumors. Patients with malignant tumors were younger when compared with those with benign tumors (age 51 years [42.8-60.0] vs 65 years [60.0-71.0] median). Malignant tumors more often demonstrated tumor invasion (69% vs 0% P < .001) and were more often associated with pericardial effusion (41% vs 7.4% P = .004). Presence of first-pass perfusion (100% vs 33% P < .001) and late gadolinium enhancement (100% vs 59.2%, P < .001) were significantly higher in malignant tumors. In logistic regression modeling, tumor invasion (P < .001) and first-pass perfusion (P < .001) were independently associated with malignancy. Furthermore, using classification and regression tree analysis, we developed a decision tree algorithm to help differentiate benign from malignant tumors (diagnostic accuracy ~90%). The algorithm-weighted cost of misclassifying a malignant tumor as benign was twice that of classifying a benign tumor as malignant.Conclusions
Our study demonstrates that cardiac magnetic resonance imaging is a useful noninvasive method for differentiating malignant from benign cardiac tumors. Tumor size, invasion, and first-pass perfusion were useful imaging characteristics in differentiating benign from malignant tumors. 相似文献![点击此处可从《Echocardiography (Mount Kisco, N.Y.)》网站下载免费的PDF全文](/ch/ext_images/free.gif)